|
1
|
Chaturvedi V and Saxena A: Heart failure
in children: Clinical aspect and management. Indian J Pediatr.
76:195–205. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Watkins DA, Johnson CO, Colquhoun SM,
Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT,
Mayosi BM, Mensah GA, et al: Global, regional, and national burden
of rheumatic heart disease, 1990-2015. N Engl J Med. 377:713–722.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Dougherty S, Beaton A, Nascimento BR,
Zühlke LJ, Khorsandi M and Wilson N: Prevention and control of
rheumatic heart disease: Overcoming core challenges in
resource-poor environments. Ann Pediatr Cardiol. 11:68–78.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Carapetis JR, Beaton A, Cunningham MW,
Guilherme L, Karthikeyan G, Mayosi BM, Sable C, Steer A, Wilson N,
Wyber R and Zühlke L: Acute rheumatic fever and rheumatic heart
disease. Nat Rev Dis Primers. 2(15084)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sorour KA: Rheumatic heart disease in
Egypt: Gloomy past and promising future. Egypt Heart J. 66:139–142.
2014.
|
|
6
|
Sarkar S, Rastogi M, Chaudhary P, Kumar R,
Arora P, Sagar V, Sahni IS, Shethi S, Thakur K, Ailawadhi S, et al:
Association of rheumatic fever & rheumatic heart disease with
plausible early & late-stage disease markers. Indian J Med Res.
145:758–766. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fernandes BA, Maher KO and Deshpande SR:
Cardiac biomarkers in pediatric heart disease: A state of art
review. World J Cardiol. 8:719–727. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nadar SK and Shaikh MM: Biomarkers in
routine heart failure clinical care. Card Fail Rev. 5:50–56.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Azevedo A, Prado AF, Antonio RC, Issa JP
and Gerlach RF: Matrix metalloproteinases are involved in
cardiovascular diseases. Basic Clin Pharmacol Toxicol. 115:301–314.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Radosinska J, Barancik M and Vrbjar N:
Heart failure and role of circulating MMP-2 and MMP-9. Panminerva
Med. 59:241–253. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wagner DR, Delagardelle C, Ernens I, Rouy
D, Vaillant M and Beissel J: Matrix metalloproteinase-9 is a marker
of heart failure after acute myocardial infarction. J Card Fail.
12:66–72. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Reményi B, Wilson N, Steer A, Ferreira B,
Kado J, Kumar K, Lawrenson J, Maguire G, Marijon E, Mirabel M, et
al: World heart federation criteria for echocardiographic diagnosis
of rheumatic heart disease-an evidence-based guideline. Nat Rev
Cardiol. 9:297–309. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jayaprasad N: Heart failure in children.
Heart views. 17:92–99. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Szczygielska I, Hernik E, Kołodziejczyk B,
Gazda A, Maślińska M and Gietka P: Rheumatic fever-new diagnostic
criteria. Reumatologia. 56:37–41. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Juneja A and Sharma S: Issues of sample
size in sensitivity and specificity analysis with special reference
to oncology. J Cancer Res Ther. 11:482–484. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dougherty S, Khorsandi M and Herbst P:
Rheumatic heart disease screening: Current concepts and challenges.
Ann Pediatr Cardiol. 10:39–49. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Isik A, Gursul C, Peker K, Aydın M, Fırat
D and Yılmaz İ: Metalloproteinases and their inhibitors in patients
with inguinal hernia. World J Surg. 41:1259–1266. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Koestenberger M, Friedberg MK, Nestaas E,
Michel-Behnke I and Hansmann G: Transthoracic echocardiography in
the evaluation of pediatric pulmonary hypertension and ventricular
dysfunction. Pulm Circ. 6:15–29. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Ross RD: The ross classification for heart
failure in children after 25 years: A review and an age-stratified
revision. Pediatr Cardiol. 33:1295–1300. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cimmino G, Ragni M, Cirillo P, Petrillo G,
Loffredo F, Chiariello M, Gresele P, Falcinelli E and Golino P:
C-reactive protein induces expression of matrix
metalloproteinase-9: A possible link between inflammation and
plaque rupture. Int J Cardiol. 168:981–986. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Harfoosh AK, Elaziz AFA, Mahmoud E and
Saleh A: Matrix metalloproteinase-9 as a potential biomarker for
inflammatory events in acute coronary syndrome, and its relation to
diabetes mellitus in these patients. Al-Azhar Assiut Med J. 13
(Suppl 1):S71–S80. 2015.
|
|
22
|
Zhao Y, Zhou X, Liao X and Yang Z:
Expression and significance of matrix metalloproteinase-1,9, tissue
inhibitor of metalloproteinase-4 and extracellular matrix
metalloproteinase inducer in the myocardium of congestive heart
failure in patients with rheumatic heart diseases. Zhong Nan Da Xue
Xue Bao Yi Xue Ban. 34:790–795. 2009.(In Chinese). PubMed/NCBI
|
|
23
|
Abou-Raya S, Naim A and Marzouk S: Cardiac
matrix remodelling in congestive heart failure: The role of matrix
metalloproteinases. Clin Invest Med. 27:93–100. 2004.PubMed/NCBI
|
|
24
|
Collier P, Watson CJ, Voon V, Phelan D,
Jan A, Mak G, Martos R, Baugh JA, Ledwidge MT and McDonald KM: Can
emerging biomarkers of myocardial remodelling identify asymptomatic
hypertensive patients at risk for diastolic dysfunction and
diastolic heart failure? Eur J Heart Fail. 13:1087–1095.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Morishita T, Uzui H, Mitsuke Y, Amaya N,
Kaseno K, Ishida K, Fukuoka Y, Ikeda H, Tama N and Yamazaki T:
Association between matrix metalloproteinase-9 and worsening heart
failure events in patients with chronic heart failure. ESC Heart
Fail. 4:321–330. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lee SD, Chen LM, Kuo WW, Shu WT, Kuo WH,
Huang EJ, Tsai CC, Li PC, Liu JY, Chen TH and Huang CY: Serum
insulin-like growth factor-axis and matrix metalloproteinases in
patients with rheumatic arthritis or rheumatic heart disease. Clin
Chim Acta. 367:62–68. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kantor PF and Rusconi P: Biomarkers in
pediatric heart failure: Their role in diagnosis and evaluating
disease progression. Prog Pediatr Cardiol. 31:53–57. 2011.
|
|
28
|
de Couto G, Ouzounian M and Liu PP: Early
detection of myocardial dysfunction and heart failure. Nat Rev
Cardiol. 7:334–44. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yan AT, Yan RT, Spinale FG, Afzal R,
Gunasinghe HR, Arnold M, Demers C, McKelvie RS and Liu PP: Plasma
matrix metalloproteinase-9 level is correlated with left
ventricular volumes and ejection fraction in patients with heart
failure. J Card Fail. 12:514–519. 2006.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yoshihisa A, Sato Y, Kanno Y, Takiguchi M,
Yokokawa T, Abe S, Misaka T, Sato T, Oikawa M, Kobayashi A, et al:
Prognostic impacts of changes in left ventricular ejection fraction
in heart failure patients with preserved left ventricular ejection
fraction. Open Heart. 7(e001112)2020.PubMed/NCBI View Article : Google Scholar
|
